Cost-minimization analysis of individually tailored or fixed-scheduled rituximab maintenance therapy for antineutrophil-cytoplasm antibody associated vasculitides

  1. Guisado-Gil, A.B.
  2. Muñoz-Burgos, M.
  3. Ortega-Eslava, A.
  4. García-Hernández, F.J.
  5. Santos-Ramos, B.
Aldizkaria:
Farmacia Hospitalaria

ISSN: 2171-8695 1130-6343

Argitalpen urtea: 2020

Alea: 44

Zenbakia: 2

Orrialdeak: 46-50

Mota: Artikulua

DOI: 10.7399/FH.11287 GOOGLE SCHOLAR

Garapen Iraunkorreko Helburuak